628 related articles for article (PubMed ID: 34384440)
1. Artificial exosomes for translational nanomedicine.
Li YJ; Wu JY; Liu J; Xu W; Qiu X; Huang S; Hu XB; Xiang DX
J Nanobiotechnology; 2021 Aug; 19(1):242. PubMed ID: 34384440
[TBL] [Abstract][Full Text] [Related]
2. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
[TBL] [Abstract][Full Text] [Related]
3. Programming assembly of biomimetic exosomes: An emerging theranostic nanomedicine platform.
Xu X; Xu L; Wen C; Xia J; Zhang Y; Liang Y
Mater Today Bio; 2023 Oct; 22():100760. PubMed ID: 37636982
[TBL] [Abstract][Full Text] [Related]
4. Engineering exosomes as refined biological nanoplatforms for drug delivery.
Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D
Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567
[TBL] [Abstract][Full Text] [Related]
5. Post isolation modification of exosomes for nanomedicine applications.
Hood JL
Nanomedicine (Lond); 2016 Jul; 11(13):1745-56. PubMed ID: 27348448
[TBL] [Abstract][Full Text] [Related]
6. Exosome-like Nanoparticles: A New Type of Nanocarrier.
Fernandes M; Lopes I; Teixeira J; Botelho C; Gomes AC
Curr Med Chem; 2020; 27(23):3888-3905. PubMed ID: 30706777
[TBL] [Abstract][Full Text] [Related]
7. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P
Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098
[TBL] [Abstract][Full Text] [Related]
8. Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications.
Tian J; Han Z; Song D; Peng Y; Xiong M; Chen Z; Duan S; Zhang L
Int J Nanomedicine; 2023; 18():7923-7940. PubMed ID: 38152837
[TBL] [Abstract][Full Text] [Related]
9. Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications.
Mondal J; Pillarisetti S; Junnuthula V; Saha M; Hwang SR; Park IK; Lee YK
J Control Release; 2023 Jan; 353():1127-1149. PubMed ID: 36528193
[TBL] [Abstract][Full Text] [Related]
10. Proteomic and Post-Translational Modification Profiling of Exosome-Mimetic Nanovesicles Compared to Exosomes.
Nasiri Kenari A; Kastaniegaard K; Greening DW; Shambrook M; Stensballe A; Cheng L; Hill AF
Proteomics; 2019 Apr; 19(8):e1800161. PubMed ID: 30790448
[TBL] [Abstract][Full Text] [Related]
11. Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges.
Syn NL; Wang L; Chow EK; Lim CT; Goh BC
Trends Biotechnol; 2017 Jul; 35(7):665-676. PubMed ID: 28365132
[TBL] [Abstract][Full Text] [Related]
12. Exosome mimetics: a novel class of drug delivery systems.
Kooijmans SA; Vader P; van Dommelen SM; van Solinge WW; Schiffelers RM
Int J Nanomedicine; 2012; 7():1525-41. PubMed ID: 22619510
[TBL] [Abstract][Full Text] [Related]
13. Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical Translation.
Burnouf T; Agrahari V; Agrahari V
Int J Nanomedicine; 2019; 14():8847-8859. PubMed ID: 32009783
[TBL] [Abstract][Full Text] [Related]
14. Exosome-like systems: Nanotechnology to overcome challenges for targeted cancer therapies.
García-Fernández J; Fuente Freire M
Cancer Lett; 2023 May; 561():216151. PubMed ID: 37001751
[TBL] [Abstract][Full Text] [Related]
15. Bioinspired exosome-like therapeutics and delivery nanoplatforms.
Lu M; Huang Y
Biomaterials; 2020 Mar; 242():119925. PubMed ID: 32151860
[TBL] [Abstract][Full Text] [Related]
16. Exosomes as nanocarriers for siRNA delivery: paradigms and challenges.
Shahabipour F; Banach M; Sahebkar A
Arch Med Sci; 2016 Dec; 12(6):1324-1326. PubMed ID: 27904525
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of Tumor Necrosis Factor-α Induced Inflammation by Umbilical Cord-Mesenchymal Stem Cell Derived Exosome-Mimetic Nanovesicles in Endothelial Cells.
Ko KW; Yoo YI; Kim JY; Choi B; Park SB; Park W; Rhim WK; Han DK
Tissue Eng Regen Med; 2020 Apr; 17(2):155-163. PubMed ID: 32026314
[TBL] [Abstract][Full Text] [Related]
18. Autologous cancer cell-derived extracellular vesicles as drug-delivery systems: a systematic review of preclinical and clinical findings and translational implications.
Li YJ; Wu JY; Hu XB; Wang JM; Xiang DX
Nanomedicine (Lond); 2019 Feb; 14(4):493-509. PubMed ID: 30694095
[TBL] [Abstract][Full Text] [Related]
19. Stem cell membrane, stem cell-derived exosomes and hybrid stem cell camouflaged nanoparticles: A promising biomimetic nanoplatforms for cancer theranostics.
Khosravi N; Pishavar E; Baradaran B; Oroojalian F; Mokhtarzadeh A
J Control Release; 2022 Aug; 348():706-722. PubMed ID: 35732250
[TBL] [Abstract][Full Text] [Related]
20. Tumor-targeted exosomes for delivery of anticancer drugs.
Raguraman R; Bhavsar D; Kim D; Ren X; Sikavitsas V; Munshi A; Ramesh R
Cancer Lett; 2023 Apr; 558():216093. PubMed ID: 36822543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
